# Scribe Therapeutics Posts $0.68 Q3 GAAP Loss Per Share, Beats Estimate

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56067
Published: 2026-11-12T23:57:18.000Z
Updated: 2026-11-12T23:57:18.000Z
Section: Business

> Revenue totaled $1.6 million, missing estimates by $2.12 million.

Scribe Therapeutics Inc. (SCTX) posted a third-quarter GAAP loss of $0.68 per share, 20 cents better than estimates, while revenue missed estimates by $2.12 million.

Revenue totaled $1.6 million.